Cargando…
Correlates of second-line type 2 diabetes medication selection in the USA
OBJECTIVE: Past research provides insufficient evidence to inform second-line diabetes medication prescribing when metformin is no longer sufficient. We evaluated patient, prescriber, and health plan characteristics associated with selection of second-line diabetes medications in the USA. RESEARCH D...
Autores principales: | Ackermann, Ronald T, Wallia, Amisha, O'Brien, Matthew J, Kang, Raymond, Cooper, Andrew, Moran, Margaret R, Liss, David T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706487/ https://www.ncbi.nlm.nih.gov/pubmed/29225892 http://dx.doi.org/10.1136/bmjdrc-2017-000421 |
Ejemplares similares
-
Glycemic Outcomes of Second-Line Diabetes Drug Choice in a Real-World Population
por: Wallia, Amisha, et al.
Publicado: (2021) -
Initiating second-line antidiabetic medication among older adults with type 2 diabetes on Metformin
por: DeCarlo, Kristen, et al.
Publicado: (2022) -
Psychological wellbeing and the association with burnout in a cohort of healthcare workers during the COVID-19 pandemic
por: Bannon, Jacqueline, et al.
Publicado: (2022) -
Comparative cardiovascular effects of GLP‐1 agonists using real‐world data
por: Wallia, Amisha, et al.
Publicado: (2023) -
Patterns and correlates of use of evidence-based interventions to control diabetes by local health departments across the USA
por: Tabak, Rachel G, et al.
Publicado: (2018)